Y
Yiannis Kallis
Researcher at Queen Mary University of London
Publications - 7
Citations - 269
Yiannis Kallis is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Cryoprecipitate & Fresh frozen plasma. The author has an hindex of 4, co-authored 7 publications receiving 124 citations. Previous affiliations of Yiannis Kallis include Barts Health NHS Trust.
Papers
More filters
Journal ArticleDOI
A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
Louise China,Nick Freemantle,Ewan Forrest,Yiannis Kallis,Stephen D. Ryder,Gavin Wright,Andrew J. Portal,Natalia Becares Salles,Derek W. Gilroy,Alastair O’Brien +9 more
TL;DR: In patients with decompensated cirrhosis, infection and increased systemic inflammation cause organ dysfunction and death in patients as discussed by the authors, and preclinical studies provide support for an anti-inflamma...
Journal ArticleDOI
British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding
Laura E. Green,Laura E. Green,Laura E. Green,Paula H B Bolton-Maggs,Craig Beattie,Rebecca Cardigan,Yiannis Kallis,Yiannis Kallis,Simon J. Stanworth,Jecko Thachil,Sharon Zahra +10 more
TL;DR: This book aims to provide a history of blood donation and transplantation practices in the United Kingdom and Europe over a 50-year period from 1989 to 2002.
Journal ArticleDOI
Addendum to the British Committee for Standards in Haematology (BCSH): Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant, 2004 (Br. J Haematol 2004,126,11-28).
Laura E. Green,Laura E. Green,Laura E. Green,Rebecca Cardigan,Craig Beattie,Paula H B Bolton-Maggs,Simon J. Stanworth,Simon J. Stanworth,Jecko Thachil,Yiannis Kallis,Yiannis Kallis,Sharon Zahra +11 more
TL;DR: Combination therapy with ruxolitinib plus 5azacytidine or continuous infusion of low dose cytarabine is feasible in patients with blast-phase myeloproliferative neoplasms.
Journal ArticleDOI
Addendum to the British Committee for Standards in Haematology (BCSH): guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatant, 2004 (Br. J Haematol 2004,126,11‐28) ‐ response to Neisser‐Svae and Heger
Laura E. Green,Rebecca Cardigan,Craig Beattie,Paula H B Bolton-Maggs,Simon J. Stanworth,Jecko Thachil,Yiannis Kallis,Sharon Zahra +7 more
TL;DR: Five day stability of thawed plasma: solvent/detergent-treated plasma comparable with fresh-frozen plasma and plasma frozen within 24 hours.
Journal ArticleDOI
Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE Trial.
Louise China,Nick Freemantle,Ewan Forrest,Yiannis Kallis,Stephen D. Ryder,Gavin Wright,Alastair O'Brien +6 more
TL;DR: In this paper, the authors examined the interaction between targeted albumin and standard care for the composite primary end point, stratifying by baseline sodium ≥ and <130 mmol/L.